FDAClass IIAugust 26, 2020

Hydrochlorothiazide 25mg tablets recall: CGMP Deviations

Hydrochlorothiazide 25mg tablets, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Mfg: Accord Healthcare, Inc, Durham, NC 27703, NDC 16729-0183-17

Why was Hydrochlorothiazide 25mg tablets recalled?

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #: 19355; Exp. Date: 3/21

Product
Hydrochlorothiazide 25mg tablets, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Mfg: Accord Healthcare, Inc, Durham, NC 27703, NDC 16729-0183-17
Recalling firm
Calvin Scott & Company, Inc.
Quantity
N/A
Distribution
Nationwide within the United States
Recall date
August 26, 2020
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls